Patient‐derived xenografts: Practical considerations for preclinical drug testing

Authors

Institutions

Publication Details

Journal
HemaSphere
Published
2025-04-01
DOI
https://doi.org/10.1002/hem3.70133
Primary Topic
3D Printing in Biomedical Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Patient‐derived xenografts: Practical considerations for preclinical drug testing

Charles E. de Bock
HemaSphere
3D Printing in Biomedical Research
article

Patient‐derived xenografts: Practical considerations for preclinical drug testing

Charles E. de Bock
article en

Abstract

No abstract available for this paper.
HemaSphereVol. 9(4)
UNSW Sydney (AU), Children's Cancer Institute Australia (AU)
Openalex Percentile: Top 93%
3D Printing in Biomedical Research
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Patient‐derived xenografts: Practical considerations for preclinical drug testing — Charles E. de Bock · HemaSphere (2025) | TGRS Research Map | TGRS